Evidence map›Paper›PMID 36672726›Full record

ArticleBiomedicines2023

Mesenchymal Stromal Cell Therapy Reverses Detrusor Hypoactivity in a Chronic Kidney Patient.

Henrique Rodrigues Scherer Coelho, Silvia Cordeiro das Neves, Jovino Nogueira da Silva Menezes, Andréia Conceição Milan Brochado Antoniolli-Silva, Rodrigo Juliano Oliveira

Open access · goldAbstract readCase Reports
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Henrique Rodrigues Scherer CoelhoCenter for Studies in Stem Cells, Cell Therapy and Genetic Toxicology (CeTroGen), Faculty of Medicine Dr. Hélio Mandetta (FAMED), Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79070-900, Mato Grosso do Sul, Brazil.ORCID 0000-0003-2438-6510
Silvia Cordeiro das NevesCenter for Studies in Stem Cells, Cell Therapy and Genetic Toxicology (CeTroGen), Faculty of Medicine Dr. Hélio Mandetta (FAMED), Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79070-900, Mato Grosso do Sul, Brazil.ORCID 0000-0003-3276-4198
Jovino Nogueira da Silva MenezesClínica Samari, Campo Grande 79020-011, Mato Grosso do Sul, Brazil.ORCID 0000-0002-1928-0802
Andréia Conceição Milan Brochado Antoniolli-SilvaCenter for Studies in Stem Cells, Cell Therapy and Genetic Toxicology (CeTroGen), Faculty of Medicine Dr. Hélio Mandetta (FAMED), Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79070-900, Mato Grosso do Sul, Brazil.ORCID 0000-0002-2525-7019
Rodrigo Juliano OliveiraCenter for Studies in Stem Cells, Cell Therapy and Genetic Toxicology (CeTroGen), Faculty of Medicine Dr. Hélio Mandetta (FAMED), Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79070-900, Mato Grosso do Sul, Brazil.ORCID 0000-0003-3514-3346
Universidade Federal de Mato Grosso do Sul · BRHospital Samaritano de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detrusor hypoactivity (DH) is characterized by low detrusor pressure or a short contraction associated with low urinary flow. This condition can progress to chronic renal failure (CRF) and result in the need for dialysis. The present case report demonstrates that a patient diagnosed with DH and CRF who received two transplants with 2 × 10

Indexed as

case reportchronic renal failurelower urinary tracturinary bladderurodynamics

Identifiers

PMID36672726
PMCPMC9855649
OpenAlexW4316467936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.